Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Skin Cancer: early-phase trial registry
14 of 42 indexed Skin Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #347 of 28,707 conditions by registered trial count.
42 US clinical trials · 14 currently recruiting · #347 of 28,707 conditions by registered trial count
Skin Cancer: 42 US clinical trials tracked, 14 recruiting.
Skin Cancer is the subject of 42 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most active sponsor is H. Lee Moffitt Cancer Center and Research Institute, running 5 of these trials.
Enrollment posture brief
Registry condition skin-cancer
OPEN 14 | RECR 33% | LATE 3 | EARLY 16 | RANK #347 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Skin Cancer lists 14 open slots (33% of 42 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Skin Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Skin Cancer is recruiting below its size-band peers.
14 of 42 indexed trials (33.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Skin Cancer trials is spread across many organizations.
H. Lee Moffitt Cancer Center and Research Institute accounts for 5 of 42 trials (11.9%). 30 distinct sponsors appear on at least one study for this condition label.
-
Most Skin Cancer trials plan to enrol fewer than 100 people.
Median target enrolment is 75 among the 41 trials that report a genuine target (sentinel values excluded). 25 of those (61%) plan for fewer than 100 participants.
-
Skin Cancer research is mostly interventional.
33 interventional and 9 observational studies make up this index (78.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
42 total, page 1 of 1
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
H. Lee Moffitt Cancer Center and Research Institute
NCT07222995
Rural Adult and Youth Sun Protection Study
University of Utah
NCT06439979
Undergraduate Skin Cancer Prevention Trial
University of Utah
NCT05634252
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
NCT05715255
Meloxicam in Mohs Micrographic Surgery
University of Oklahoma
NCT07200544
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
Bruce Robinson, MD
NCT07010692
DNA Repair Activity in the Skin of Day and Night Shift Workers
Wright State University
NCT04122456
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
Dana-Farber Cancer Institute
NCT06298734
Cryoablation+Ipilimumab+Nivolumab in Melanoma
Massachusetts General Hospital
NCT05779423
Pilot Trial of Supplemental Vitamin A and Nicotinamide
Rhode Island Hospital
NCT05702398
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
Dana-Farber Cancer Institute
NCT06664151
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
University of Wisconsin, Madison
NCT06608511
Raman Spectroscopy and Skin Cancer
Renee Farrell
NCT06384924
TIL Therapy in cSCC and MCC
Karam Khaddour, MD, MS
NCT07288073
A Model for Genetic Susceptibility: Melanoma
Memorial Sloan Kettering Cancer Center
NCT00591500
In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
Memorial Sloan Kettering Cancer Center
NCT00588315
Patient Satisfaction in Cutaneous Surgery
Northwestern University
NCT01535963
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
NCT03071406
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
NYU Langone Health
NCT07177638
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
NCT05704985
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
Memorial Sloan Kettering Cancer Center
NCT05574101
XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
H. Lee Moffitt Cancer Center and Research Institute
NCT02721459
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
H. Lee Moffitt Cancer Center and Research Institute
NCT03543969
Sun-safe Habits Intervention and Education
University of Utah
NCT04341064
Online Tailored Interventions & Relational Agents for Exercise and Sun Protection
University of Rhode Island
NCT01458002
DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer
DermaSensor
NCT06690086
Skin Cancer Prevention in a Pediatric Population
University of Colorado, Denver
NCT01464957
Melanoma Risk Assessment & Tailored Intervention
University of Pennsylvania
NCT01356771
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
University of California, Davis
NCT01820234
Phase II Trial of Allovectin-7® for Metastatic Melanoma
Vical
NCT00044356
Comparison Of Video-based Versus Written Patient Education on Sunscreen
University of California, Davis
NCT00826306
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
Case Comprehensive Cancer Center
NCT06167096
Multi-Center Study to Evaluate the Performance of DermDx for Primary Care Physicians in the Detection of Skin Cancers
MetaOptima Technology
NCT06463860
EUREKA: Evaluating Ultraviolet Radiation Exposure in Kids for Adaptive Intervention
University of Utah
NCT07204704
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
Mayo Clinic
NCT00578214
Development and Validation of a New Digital Dermatoscope in the United States
Barco
NCT04047316
Health Communication in Families
Memorial Sloan Kettering Cancer Center
NCT00597961
Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen
Yale University
NCT05736224
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Emory University
NCT01526486
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
Sue Yom
NCT01835626
Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
H. Lee Moffitt Cancer Center and Research Institute
NCT02032810
Study of Talabostat and Cisplatin in Advanced Melanoma
Point Therapeutics
NCT00083252
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 8 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Skin Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Skin Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Skin Cancer page
42 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Skin Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- H. Lee Moffitt Cancer Center and Research Institute sponsors the most Skin Cancer trials on record, review their full trial history before evaluating a specific study. See H. Lee Moffitt Cancer Center and Research Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Skin Cancer condition card totals 42 registered trials; most-linked intervention Ipilimumab; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.